Search research articles
Contact Us
Filters
Showing results (141-150 of 174) with videos related to
Page
of 18
Sort By:
Blood
|
January 21, 2022
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
Oriana Miltiadous, Nicholas R Waters, Hana Andrlová, et al.
Blood Advances
|
April 20, 2023
Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
Richard J Lin, Soo Jung Kim, Samantha Brown, et al.
The Journal of Clinical Investigation
|
September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
Gunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2016
Ex Vivo CD34<sup>+</sup>-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response
Pere Barba, Patrick Hilden, Sean M Devlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
Leukemia & Lymphoma
|
April 2, 2020
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
Richard J Lin, Laure Michaud, Stephanie M Lobaugh, et al.
Journal of Hematology & Oncology
|
April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
Doris Leithner, Jessica R Flynn, Sean M Devlin, et al.
Transplantation and Cellular Therapy
|
May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Corrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 16, 2015
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
Robert R Jenq, Ying Taur, Sean M Devlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma
Jae H Park, M Lia Palomba, Karlo Perica, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 174) with videos related to
Sort By:
Page
of 18
Blood
|
January 21, 2022
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
Oriana Miltiadous, Nicholas R Waters, Hana Andrlová, et al.
Blood Advances
|
April 20, 2023
Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
Richard J Lin, Soo Jung Kim, Samantha Brown, et al.
The Journal of Clinical Investigation
|
September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
Gunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2016
Ex Vivo CD34<sup>+</sup>-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response
Pere Barba, Patrick Hilden, Sean M Devlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
Leukemia & Lymphoma
|
April 2, 2020
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
Richard J Lin, Laure Michaud, Stephanie M Lobaugh, et al.
Journal of Hematology & Oncology
|
April 22, 2024
Conventional and novel [<sup>18</sup>F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
Doris Leithner, Jessica R Flynn, Sean M Devlin, et al.
Transplantation and Cellular Therapy
|
May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
Corrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 16, 2015
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
Robert R Jenq, Ying Taur, Sean M Devlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma
Jae H Park, M Lia Palomba, Karlo Perica, et al.
Page
of 18